Pay in 4 interest-free payments of $7.34 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Interim Analysis of a Phase II Study of the Glutaminase Inhibitor Telaglenastat (CB-839) in Combination with Azacitidine in Advanced Myelodysplastic Syndrome (MDS)
Any item not removed within this time frame will be assessed a $10 per item relocation fee for smaller items (boxable) and a $25 per item relocation fee for larger items (non-boxable)
I am predicting consumers will gravitate towards this finished type of product and the old way of rolling joints will be something of the past," said John Miller, President and CEO of THC BioMed
RFID:Image ID:GJ4NTM Image details Contributor: YAY Media AS Image ID: GJ4NTM File size: 34.9 MB (1.7 MB Compressed download) Releases: Model - no | Property - noDo I need a release
US$ 24.15
US$ 24.46
US$ 24.25
US$ 27.12
US$ 25.93
US$ 23.19
US$ 28.08
US$ 26.29
US$ 27.64
